Angle News - AGL

Best deals to access real time data!
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
Real-time Level 2 for London Stock Exchange
Monthly Subscription
for only
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
VAT not included
Stock Name Stock Symbol Market Stock Type
Angle Plc AGL London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
-1.00 -0.78% 126.50 09:55:26
Open Price Low Price High Price Close Price Previous Close
129.00 126.00 131.00 126.50 127.50
more quote information »
Industry Sector

Recent News

Date Time Source Heading
1/21/202206:25ALNCTAKING AIM: Berenberg hails Angle's cancer diagnosis..
1/21/202204:57ALNCStudy shows potential for Angle's Parsortix system in..
1/21/202201:00RNSNONAngle PLC Potential in immunotherapy treatment selection
1/17/202209:16ALNCAngle says Parsortix system could replace cancer tissue..
1/17/202201:01RNSNONAngle PLC Concordance of Parsortix with tissue biopsy
1/13/202206:06ALNCAngle cancer study delayed as accreditation process for labs..
1/13/202201:00UKREGAngle PLC Update on lab accreditation and ovarian study
1/10/202213:34ALNCTRADING UPDATES: Harvest Minerals sales jump; Quartix..
1/10/202201:00RNSNONAngle PLC Insight into drug resistance in NSCLC
12/22/202112:29UKREGAngle PLC Issue of Equity
12/01/202112:10UKREGAngle PLC Issue of Equity
12/01/202101:00RNSNONAngle PLC Parsortix in RNA analysis of CTCs as tool in NSCLC
11/26/202111:33UKREGAngle PLC Issue of Equity
11/17/202104:32UKREGAngle PLC Issue of Equity
11/15/202108:15ALNCEXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new..
11/15/202101:00UKREGAngle PLC Issue of LTIP Options and Share Options
11/12/202111:51UKREGAngle PLC Issue of Equity
11/12/202101:00RNSNONAngle PLC Participation at Jefferies healthcare conference
11/11/202101:00RNSNONAngle PLC Parsortix system showcased at NCRI Festival
11/10/202111:40UKREGAngle PLC Issue of Equity
11/02/202102:00UKREGAngle PLC Change of Adviser
10/21/202111:25UKREGAngle PLC Issue of Equity
10/15/202111:45UKREGAngle PLC Issue of Equity
9/30/202110:02UKREGAngle PLC Issue of Equity
9/30/202109:12ALNCEXTRA: Angle considers Nasdaq listing to support growth..
9/30/202105:07ALNCAngle first-half loss widens, crucial FDA decision expected..
9/30/202101:00UKREGAngle PLC Interim Results
9/27/202111:52ALNCIN BRIEF: Angle notes studies supporting Parsortix system in..
9/27/202101:00RNSNONAngle PLC Parsortix demonstrates ability to isolate CTCs
9/22/202115:49ALNCIN BRIEF: Angle's Parsortix used in Spanish study to find..
9/22/202101:00RNSNONAngle PLC Study shows use of Parsortix to assess PD-L1
9/21/202101:35ALNCIN BRIEF: Angle's Parsortix enables gene analysis in cancer..
9/20/202101:00RNSNONAngle PLC Parsortix enables gene expression analysis in mPCa
9/07/202101:00UKREGAngle PLC Notice of Interim Results and Webcast
8/24/202101:00UKREGAngle PLC Director/PDMR Shareholding
8/09/202101:00RNSNONAngle PLC Study highlights superior performance of Parsortix
8/06/202107:17UKREGAngle PLC Issue of Equity
8/03/202109:13UKREGAngle PLC Issue of Equity
7/28/202112:07ALNCTRADING UPDATES: United Oil & Gas in North Sea sale; Trifast..
7/28/202101:00UKREGAngle PLC Contract secured for bespoke assay development
7/09/202114:19ALNCIN BRIEF: Angle's Parsortix successfully used to harvest..
7/09/202101:00RNSNONAngle PLC Harvesting CTCs from brain metastasis patients
7/07/202112:34UKREGAngle PLC Director/PDMR Shareholding
7/02/202104:45UKREGAngle PLC Issue of Equity
6/30/202109:44UKREGAngle PLC Result of AGM
6/25/202108:08ALNCIN BRIEF: Angle raises GBP20.0 million to fund FDA approval..
6/25/202101:00UKREGAngle PLC Result of Accelerated Bookbuild
6/24/202113:30ALNCIN BRIEF: Angle to raise GBP20 million through shares..
6/24/202112:28UKREGAngle PLC Accelerated bookbuild to raise up to GBP20m
6/18/202107:23ALNCTRADING UPDATES: DP Poland sales improve; Braveheart swings..
See more news about this stock »
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220121 17:19:50